| Ident. | Authors (with country if any) | Title |
|---|
| 000369 |
Jason A. Roberts [Australie] ; Sanjoy K. Paul [Australie] ; Murat Akova [Turquie] ; Matteo Bassetti [Italie] ; Jan J. De Waele [Belgique] ; George Dimopoulos [Grèce] ; Kirsi-Maija Kaukonen [Finlande] ; Despoina Koulenti [Australie, Grèce] ; Claude Martin [France] ; Philippe Montravers [France] ; Jordi Rello [Espagne] ; Andrew Rhodes [Royaume-Uni] ; Therese Starr [Australie] ; Steven C. Wallis [Australie] ; Jeffrey Lipman [Australie] | DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically III Patients? |
| 001291 |
Alexis Tabah [France, Grèce] ; Despoina Koulenti [Grèce] ; Kevin Laupland [France, Canada] ; Benoit Misset [France] ; Jordi Valles [Espagne] ; Frederico Bruzzi De Carvalho [Brésil] ; Jose Artur Paiva [Portugal] ; Nahit Cakar [Turquie] ; XIAOCHUN MA [République populaire de Chine] ; Philippe Eggimann [Suisse] ; Massimo Antonelli [Italie] ; Marc J. M. Bonten [Pays-Bas] ; Akos Csomos [Hongrie] ; Wolfgang A. Krueger [Allemagne] ; Adam Mikstacki [Pologne] ; Jeffrey Lipman [Australie] ; Pieter Depuydt [Belgique] ; Aurélien Vesin [France, Grèce] ; Maité Garrouste-Orgeas [France, Grèce] ; Jean-Ralph Zahar [France] ; Stijn Blot [Belgique] ; Jean Carlet [France] ; Christian Brun-Buisson [France] ; Claude Martin [France] ; Jordi Rello ; Georges Dimopoulos [Grèce] ; Jean-François Timsit [France] | Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study |
| 001382 |
Marie-Patrice Halle [France, Cameroun] ; Alexandre Hertig [France] ; Andre Pascal Kengne [Australie] ; Gloria Ashuntantang [Cameroun] ; Eric Rondeau [France] ; Christophe Ridel [France] | Acute pulmonary oedema in chronic dialysis patients admitted into an intensive care unit |
| 001985 |
H Kan Hanberger [Suède] ; Sten Walther [Suède] ; Marc Leone [France] ; Philip S. Barie [États-Unis] ; Jordi Rello [Espagne] ; Jeffrey Lipman [Australie] ; John C. Marshall [Canada] ; Antonio Anzueto [États-Unis] ; Yasser Sakr [Allemagne] ; Peter Pickkers [Pays-Bas] ; Peter Felleiter [Suisse] ; Milo Engoren [États-Unis] ; Jean-Louis Vincent [Belgique] | Increased mortality associated with meticillin-resistant Staphylococcus aureus (MRSA) infection in the Intensive Care Unit: results from the EPIC II study |
| 002220 |
S. Gubbels [Danemark, Suède] ; A. Perner [Danemark] ; P. Valentiner-Branth [Danemark] ; K. M Lbak [Danemark] | National surveillance of pandemic influenza A(H1N1) infection-related admissions to intensive care units during the 2009-10 winter peak in Denmark: two complementary approaches |
| 002A46 |
Jean-Louis Vincent [Belgique] ; Jordi Rello [Espagne] ; John Marshall [Canada] ; Eliezer Silva [Brésil] ; Antonio Anzueto [États-Unis] ; Claude D. Martin [France] ; Rui Moreno [Portugal] ; Jeffrey Lipman [Australie] ; Charles Gomersall [Hong Kong] ; Yasser Sakr [Allemagne] ; Konrad Reinhart [Allemagne] | International Study of the Prevalence and Outcomes of Infection in Intensive Care Units |
| 004832 |
Edward Abraham [États-Unis] ; Peter Andrews [Royaume-Uni] ; Massimo Antonelli [Italie] ; Laurent Brochard [France] ; Christian Brun-Buisson [France] ; Geoffrey Dobb [Australie] ; Jean-Yves Fagon [France] ; Johan Groeneveld [Pays-Bas] ; Jordi Mancebo [Espagne] ; Philipp Metnitz [Autriche] ; Stefano Nava [Italie] ; Michael Pinsky [États-Unis] ; Peter Radermacher [Allemagne] ; Marco Ranieri [Italie] ; Christian Richard [France] ; Robert Tasker [Royaume-Uni] ; Benoit Vallet [France] | Year in review in intensive care medicine-2003. Part 3: Intensive care unit organization, scoring, quality of life, ethics, neonatal and pediatrics, and experimental |
| 005939 |
Achilles K. Papavasiliou [Liban] ; Kimberly S. Harbaugh [Liban] ; Nancy J. Birkmeyer [Liban] ; James M. Feeney [Liban] ; Paul B. Martin [Liban] ; Charlotte Faccio [Liban] ; Robert E. Harbaugh [Liban] ; J. Philippon [France] ; N. W. C. Dorsch [Australie] | Clinical outcomes of aneurysmal subarachnoid hemorrhage patients treated with oral diltiazem and limited intensive care management. Commentary |
